BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11994476)

  • 1. Expansion of NK cells with reduction of their inhibitory Ly-49A, Ly-49C, and Ly-49G2 receptor-expressing subsets in a murine helminth infection: contribution to parasite control.
    Korten S; Volkmann L; Saeftel M; Fischer K; Taniguchi M; Fleischer B; Hoerauf A
    J Immunol; 2002 May; 168(10):5199-206. PubMed ID: 11994476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
    Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
    J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.
    Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ
    Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of murine NK cells into distinct subsets based on variable expression of the IL-12R beta 2 subunit.
    Chakir H; Camilucci AA; Filion LG; Webb JR
    J Immunol; 2000 Nov; 165(9):4985-93. PubMed ID: 11046026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ly-49 family: regulation of cytokine production in murine NK cells.
    Ortaldo JR; Mason LH; Gregorio TA; Stoll J; Winkler-Pickett RT
    J Leukoc Biol; 1997 Sep; 62(3):381-8. PubMed ID: 9307078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras.
    Manilay JO; Waneck GL; Sykes M
    Int Immunol; 1998 Dec; 10(12):1943-55. PubMed ID: 9885916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
    Basiri H; Kiura K; DeNardin EG; Nakamura I
    J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties.
    Brennan J; Mager D; Jefferies W; Takei F
    J Exp Med; 1994 Dec; 180(6):2287-95. PubMed ID: 7964501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
    Kim S; Yokoyama WM
    Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of Ly-49 receptor expression are determined by the frequency of interactions with MHC ligands: evidence against receptor calibration to a "useful" level.
    Manilay JO; Waneck GL; Sykes M
    J Immunol; 1999 Sep; 163(5):2628-33. PubMed ID: 10453002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ly-49D receptor activates murine natural killer cells.
    Mason LH; Anderson SK; Yokoyama WM; Smith HR; Winkler-Pickett R; Ortaldo JR
    J Exp Med; 1996 Dec; 184(6):2119-28. PubMed ID: 8976168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
    Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
    J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NK2.1 receptor is encoded by Ly-49C and its expression is regulated by MHC class I alleles.
    Gosselin P; Lusignan Y; Brennan J; Takei F; Lemieux S
    Int Immunol; 1997 Apr; 9(4):533-40. PubMed ID: 9138013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-restricted NKT cells: an interstrain comparison.
    Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
    J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell inhibitory receptor Ly-49C residues involved in MHC class I binding.
    Sundbäck J; Achour A; Michaëlsson J; Lindström H; Kärre K
    J Immunol; 2002 Jan; 168(2):793-800. PubMed ID: 11777974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2).
    Mason LH; Ortaldo JR; Young HA; Kumar V; Bennett M; Anderson SK
    J Exp Med; 1995 Aug; 182(2):293-303. PubMed ID: 7629495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.